These phenotypes are consistent with previous observations that Myc-amplified GBM subtypes—typified by elevated glycolytic flux—exhibit heightened sensitivity to metabolic perturbation, particularly via NAD+ salvage inhibition [14]. Here, MYC is linked to glioblastoma.